WhatDoTheyPrescribe.com is an educational resource explaining real-world prescribing patterns and is not a substitute for professional medical advice.

What do they prescribe?

Specify State (optional)

Search by Prescriber

Search by Drug

Doctors Who Prescribe Aripiprazole (Opipza, Abilify) in Louisiana

Also known as: Opipza, Abilify

Find doctors, physicians, and healthcare providers who prescribe Aripiprazole in Louisiana. This page lists the top prescribers of Aripiprazole based on Medicare Part D data, including the number of claims, patients served, and total drug costs.

What is Aripiprazole?

Aripiprazole is indicated for the treatment of: • Schizophrenia • Irritability Associated with Autistic Disorder • Treatment of Tourette’s Disorder Aripiprazole is an atypical antipsychotic. The oral formulations are indicated for: • Schizophrenia (14.1) • Irritability Associated with Autistic Disorder (14.4) • Treatment of Tourette’s disorder (14. It belongs to a class of drugs known as atypical antipsychotic.

Total Claims in Louisiana
54,785
1.6% of all Aripiprazole prescriptions nationwide
Total Beneficiaries in Louisiana
112,833
Total Cost in Louisiana
$10,637,253

Top Prescribers in LA(0+)

Specify State (optional)

PrescriberLocationTypeClaimsBeneficiariesCost
Loading more data in background...

Find Aripiprazole doctors in other states

AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming
Data Source: Prescribing data aggregated from the official CMS.gov Medicare Part D Prescribers by Provider and Drug dataset, published by the Centers for Medicare & Medicaid Services.
Data Current As Of: 2023 (most recent CMS release). Individual prescriber counts below 11 are suppressed by CMS for patient privacy.